Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Савченко Илья Вячеславович
Observed names:
I. Savchenko,
I. V. Savchenko,
I.V. Savchenko,
Ilya V. Savchenko
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0000-0003-2142-661X
Observed ORCIDs:
0000-0003-2142-661X,
0009-0003-9964-4673
OpenAlex ID:
A5067427182
Second line drug therapy for biliary cancer
2022
·
I. V. Savchenko
, V. V. Breder
, et al.
·
Meditsinskiy sovet = Medical Council
·
3
PDF
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
2024
·
Ilya V. Savchenko
, Ivan S. Stilidi
, et al.
·
Journal of Modern Oncology
·
2
PDF
Intraoperative lymphography with indocyanine green experience in liver resection planning in patients with biliary cancer
2025
·
A. V. Korshak
, D. V. Podluzhnyi
, et al.
·
Research and Practical Medicine Journal
·
1
PDF
Surgical treatment and prognostic factors in perihilar tumors
2024
·
A.N. Polyakov
, Yu.I. Patyutko
, et al.
·
Pirogov Russian Journal of Surgery
·
1
Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)
2023
·
I. A. Dzhanyan
, M. S. Novruzbekov
, et al.
·
Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH)
·
1
PDF
Pemigatinib in the real-world management of advanced intrahepatic FGFR2-positive cholangiocarcinoma
2026
·
M. N. Khagazheeva
, A. R. Zaretsky
, et al.
·
Meditsinskiy sovet = Medical Council
PDF
Results of the of neoadjuvant polychemotherapy in the combined treatment of gastric cancer
2026
·
A. P. Dyatlov
, I. V. Mikhailov
, et al.
·
Health and Ecology Issues
PDF
Neoadjuvant chemotherapy for resectable intrahepatic cholangiocarcinoma: short-term outcomes
2026
·
A. Sh. Umirzokov
, A. V. Korshak
, et al.
·
Surgery and Oncology
16P Impact of selected morphological factors on RFS and OS in patients with fibrolamellar carcinoma undergoing surgical treatment
2026
·
E. Antonova
, E. Moroz
, et al.
·
ESMO rare cancers.
PDF
20P Epithelioid hemangioendothelioma of the liver. Experience in treating a rare tumor
2026
·
E. Antonova
, I. Dzhanyan
, et al.
·
ESMO rare cancers.
PDF
Effectiveness and safety of Atezolizumab and Bevacizumab as conversion therapy for unresectable or advanced HCC in real-world clinical practice in Russia: Multicenter retrospective observational study
2026
·
I. A. Dzhanyan
, O. D. Olisov
, et al.
·
Meditsinskiy sovet = Medical Council
PDF
Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: a retrospective study
2025
·
Elena Yu. Antonova
, Irina A. Janyan
, et al.
·
Journal of Modern Oncology
PDF
Результаты применения таргетной терапии ленватинибом в качестве первой линии терапии при распространенном гепатоцеллюлярном раке
2025
·
Антонова Елена Юрьевна
, Джанян Ирина Анатольевна
, et al.
·
Journal of Modern Oncology
Эффективность и безопасность атезолизумаба и бевацизумаба в конверсионной терапии пациентов с нерезектабельным и распространенным гепатоцеллюлярным раком в российской реальной клинической практике: мультицентровое ретроспективное обсервационное исследование
2025
·
Джанян Ирина Анатольевна
, Олисов Олег Даниелович
, et al.
·
Медицинский Совет
Experience with the use of nivolumab and ipilimumab in metastatic fibrolamellar liver carcinoma
2024
·
E. Yu. Antonova
, I. A. Dzhanyan
, et al.
·
Meditsinskiy sovet = Medical Council
Molecularly targeted therapy for biliary cancer
2024
·
I.V. Savchenko
, I.A. Dzhanyan
, et al.
·
P A Herzen Journal of Oncology
The Role and Mechanisms of Epithelial-mesenchymal Transition in the Progression of Melanoma
2020
·
S. V. Chulkova
, D. A. Ryabchikov
, et al.
·
Russian Journal of Biotherapy
Show more works
View as search
Works count:
17
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type